<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02542579</url>
  </required_header>
  <id_info>
    <org_study_id>KUH1010691</org_study_id>
    <nct_id>NCT02542579</nct_id>
  </id_info>
  <brief_title>Gastric Microbiota and Helicobacter Pylori Test Findings</brief_title>
  <official_title>Impact of the Composition of Gastric Microbiota on the Accuracy of Helicobacter Pylori Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konkuk University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konkuk University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diagnostic tests for Helicobacter pylori infection consist of noninvasive tests (i.e., urea
      breath test, serum antibody, stool antigen, urine antibody) and invasive tests (i.e.,
      histology, Giemsa stain, Warthin-Starry stain, Gram stain, culture, rapid urease test).

      Discrepancies between the tests may occur, and further induce problems for the diagnosis and
      treatment for H. pylori infection.

      Various types of microbiota can live together in a human stomach, and can be diagnosed using
      16S ribosomal ribonucleic acid (rRNA) pyrosequencing analysis based on multiplex polymerase
      chain reaction (PCR) method.

      With the progress of gastric atrophy, the numbers of gastric microbiota may increase due to
      the low acidity of the intragastric condition.

      As a consequence, H. pylori are derived out the stomach, and may show a negative findings on
      the H. pylori assays.

      The aim of this study is to evaluate how the composition of gastric microbiota differ
      according to the H. pylori test findings.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Molecular methods have been increasingly used for diagnosing different aspects of microbiota.
      PCR is a DNA amplification procedure resulting in rapid production of multiple copies of a
      DNA &quot;target&quot; sequence. The technique may be applied on material from gastric biopsies or any
      organic fluids (stools, saliva and gastric juice). Its extreme sensitivity and specificity
      enable a single DNA copy of the microorganism in the examined material to be identified. This
      property, on the other hand, also increases the odds of false-positives occurring, either
      because of the presence of residues of the microorganism in the material or their presence in
      the set of instruments used in the endoscopy and their occasionally not being properly
      sterilized and cleaned.

      Very contaminated materials, with mixed flora, may also contain bacteria with a gene sequence
      similar to those of H. pylori and also lead to false-positive results. Nevertheless, the PCR
      sensitivity and specificity for the H. pylori infection range from 90 to 100%. The aim of
      this study is to evaluate how the composition of gastric microbiota differ according to the
      H. pylori test findings using 16S rRNA pyrosequencing analysis based on multiplex PCR method.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Genotyping for gastric microbiota</measure>
    <time_frame>up to 2 months</time_frame>
    <description>16S rRNA pyrosequencing analysis findings</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Helicobacter pylori infiltration on the gastric mucosa</measure>
    <time_frame>up to 2 months</time_frame>
    <description>0=none, 1=mild, 2= moderate, 3=marked infiltration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute inflammatory cell infiltration</measure>
    <time_frame>up to 2 months</time_frame>
    <description>0=none, 1=mild, 2= moderate, 3=marked infiltration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic inflammatory cell infiltration</measure>
    <time_frame>up to 2 months</time_frame>
    <description>0=none, 1=mild, 2= moderate, 3=marked infiltration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of gastric atrophy</measure>
    <time_frame>up to 2 months</time_frame>
    <description>0=none, 1=mild, 2= moderate, 3=marked degree</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of intestinal metaplasia</measure>
    <time_frame>up to 2 months</time_frame>
    <description>0=none, 1=mild, 2= moderate, 3=marked degree</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Special Giemsa stain</measure>
    <time_frame>up to 2 months</time_frame>
    <description>0=negative staining, 1=positive staining</description>
  </other_outcome>
  <enrollment type="Actual">121</enrollment>
  <condition>Bacterial Infections</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>16S rRNA pyrosequencing analysis</intervention_name>
    <description>For H. pylori identification and genotyping, VAI-F(5'-ATGGAAATACAACAAACACAC-3') and VAI-R(5'-CTGCTTGAATGCGCCAAAC-3') will be used. For vacuolating cytotoxin A (vacA) s1/s2, VAG-F (5'-CAATCTGTCCAATCAAGCGAG-3') and VAG-R(5'-GCGTCAAAATAATTCCAAGG-3') will be used, and for cytotoxin-associated gene A (cagA), cag5c-F(5'-GTTGATAACGCTGTCGCTTC-3') and cag3c-R(5'-GGGTTGTAT GATATTTTCCATAA-3') will be used.</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Microbiota on the gastric biopsied specimen
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult population who visited our center for gastrointestinal endoscopy and H. pylori tests
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who agreed on non-invasive H. pylori tests on the day of upper
             gastrointestinal endoscopy with gastric biopsies for invasive H.pylori tests at our
             center

          -  Age &gt;20 years old

        Exclusion Criteria:

          -  Underlying disease(s) that requires managements

          -  Recent intake of drug(s)

          -  History of gastrectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sun-Young Lee, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Konkuk University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Konkuk University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>05030</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Konkuk University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>143729</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Lee SY, Moon HW, Hur M, Yun YM. Validation of western Helicobacter pylori IgG antibody assays in Korean adults. J Med Microbiol. 2015 May;64(Pt 5):513-8. doi: 10.1099/jmm.0.000050. Epub 2015 Mar 9.</citation>
    <PMID>25752852</PMID>
  </reference>
  <reference>
    <citation>Lee SP, Lee SY, Kim JH, Sung IK, Park HS, Shim CS, Moon HW. Correlation between Helicobacter pylori infection, IgE hypersensitivity, and allergic disease in Korean adults. Helicobacter. 2015 Feb;20(1):49-55. doi: 10.1111/hel.12173. Epub 2014 Sep 25.</citation>
    <PMID>25257099</PMID>
  </reference>
  <reference>
    <citation>Lee SY. Future candidates for indications of Helicobacter pylori eradication: do the indications need to be revised? J Gastroenterol Hepatol. 2012 Feb;27(2):200-11. doi: 10.1111/j.1440-1746.2011.06961.x. Review.</citation>
    <PMID>22098099</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2015</study_first_submitted>
  <study_first_submitted_qc>September 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2015</study_first_posted>
  <last_update_submitted>August 29, 2016</last_update_submitted>
  <last_update_submitted_qc>August 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konkuk University Medical Center</investigator_affiliation>
    <investigator_full_name>Sun-Young Lee</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacterial Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

